Murua, Isi Henry Leonard, has expressed concern at the exorbitant and seemingly unfair price of the acquisition of the Misima ...

AbbVie is undervalued with strong EPS growth, rising immunology revenue, and a 3.43% yield. Check out ABBV's robust pipeline ...